Hepatic acyl-coenzyme A: cholesterol acyltransferase-2 expression is decreased in mice with hyperhomocysteinemia

Angela M. Devlin, Ranji Singh, Teodoro Bottiglieri, Sheila M. Innis, Tim J. Green

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Alterations in lipid metabolism may contribute to the pathology of hyperhomocysteinemia (HHcy). Our objective in this study was to test the hypothesis that HHcy is associated with changes in liver acyl CoA:cholesterol acyl transferase 2 (ACAT2) expression and cholesteryl esters (CE) in mice with HHcy. ACAT2 is encoded by Soat2 and functions to catalyze the esterification of cholesterol with acyl-CoA. Mice heterozygous for disruption of the cystathionine-β-synthase gene (Cbs +/-) and C57BL/6 mice (Cbs +/+) were fed a control diet or a diet high in L-methionine (8.60 g/kg) and low in folic acid (0.20 mg/kg) to induce HHcy (HH diet). Lower Soat2 mRNA (P < 0.05) and ACAT protein (P < 0.001), higher total oleic acid [18:1(n-9)], and lower CE 18:1(n-9) was found in liver from Cbs +/2 mice fed the HH diet, with higher plasma total homocysteine concentrations, than Cbs +/+ mice fed the control diet (35.01 ± 5.6 vs. 2.21 ± 0.6 μmol/L, respectively). In silico searches identified a CpG-rich region in the 5′ portion of the Soat2 gene, which was differentially methylated (P < 0.05) in Cbs +/- mice fed the HH diet than in Cbs +/+ mice fed the control diet and was accompanied by higher (P < 0.05) B1 repeat element methylation, an indicator of global de novo methylation. These findings show altered methylation and expression of Soat2/ACAT2 in liver from mice with HHcy and suggest a role for changes in liver CE in the pathology of HHcy.

LanguageEnglish
Pages231-237
Number of pages7
JournalJournal of Nutrition
Volume140
Issue number2
DOIs
Publication statusPublished - 2010

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Devlin, Angela M. ; Singh, Ranji ; Bottiglieri, Teodoro ; Innis, Sheila M. ; Green, Tim J. / Hepatic acyl-coenzyme A : cholesterol acyltransferase-2 expression is decreased in mice with hyperhomocysteinemia. In: Journal of Nutrition. 2010 ; Vol. 140, No. 2. pp. 231-237.
@article{1281da0d8fce46da93a722f1a111bd84,
title = "Hepatic acyl-coenzyme A: cholesterol acyltransferase-2 expression is decreased in mice with hyperhomocysteinemia",
abstract = "Alterations in lipid metabolism may contribute to the pathology of hyperhomocysteinemia (HHcy). Our objective in this study was to test the hypothesis that HHcy is associated with changes in liver acyl CoA:cholesterol acyl transferase 2 (ACAT2) expression and cholesteryl esters (CE) in mice with HHcy. ACAT2 is encoded by Soat2 and functions to catalyze the esterification of cholesterol with acyl-CoA. Mice heterozygous for disruption of the cystathionine-β-synthase gene (Cbs +/-) and C57BL/6 mice (Cbs +/+) were fed a control diet or a diet high in L-methionine (8.60 g/kg) and low in folic acid (0.20 mg/kg) to induce HHcy (HH diet). Lower Soat2 mRNA (P < 0.05) and ACAT protein (P < 0.001), higher total oleic acid [18:1(n-9)], and lower CE 18:1(n-9) was found in liver from Cbs +/2 mice fed the HH diet, with higher plasma total homocysteine concentrations, than Cbs +/+ mice fed the control diet (35.01 ± 5.6 vs. 2.21 ± 0.6 μmol/L, respectively). In silico searches identified a CpG-rich region in the 5′ portion of the Soat2 gene, which was differentially methylated (P < 0.05) in Cbs +/- mice fed the HH diet than in Cbs +/+ mice fed the control diet and was accompanied by higher (P < 0.05) B1 repeat element methylation, an indicator of global de novo methylation. These findings show altered methylation and expression of Soat2/ACAT2 in liver from mice with HHcy and suggest a role for changes in liver CE in the pathology of HHcy.",
author = "Devlin, {Angela M.} and Ranji Singh and Teodoro Bottiglieri and Innis, {Sheila M.} and Green, {Tim J.}",
year = "2010",
doi = "10.3945/jn.109.112920",
language = "English",
volume = "140",
pages = "231--237",
journal = "Journal of Nutrition",
issn = "0022-3166",
publisher = "American Society for Nutrition",
number = "2",

}

Hepatic acyl-coenzyme A : cholesterol acyltransferase-2 expression is decreased in mice with hyperhomocysteinemia. / Devlin, Angela M.; Singh, Ranji; Bottiglieri, Teodoro; Innis, Sheila M.; Green, Tim J.

In: Journal of Nutrition, Vol. 140, No. 2, 2010, p. 231-237.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Hepatic acyl-coenzyme A

T2 - Journal of Nutrition

AU - Devlin, Angela M.

AU - Singh, Ranji

AU - Bottiglieri, Teodoro

AU - Innis, Sheila M.

AU - Green, Tim J.

PY - 2010

Y1 - 2010

N2 - Alterations in lipid metabolism may contribute to the pathology of hyperhomocysteinemia (HHcy). Our objective in this study was to test the hypothesis that HHcy is associated with changes in liver acyl CoA:cholesterol acyl transferase 2 (ACAT2) expression and cholesteryl esters (CE) in mice with HHcy. ACAT2 is encoded by Soat2 and functions to catalyze the esterification of cholesterol with acyl-CoA. Mice heterozygous for disruption of the cystathionine-β-synthase gene (Cbs +/-) and C57BL/6 mice (Cbs +/+) were fed a control diet or a diet high in L-methionine (8.60 g/kg) and low in folic acid (0.20 mg/kg) to induce HHcy (HH diet). Lower Soat2 mRNA (P < 0.05) and ACAT protein (P < 0.001), higher total oleic acid [18:1(n-9)], and lower CE 18:1(n-9) was found in liver from Cbs +/2 mice fed the HH diet, with higher plasma total homocysteine concentrations, than Cbs +/+ mice fed the control diet (35.01 ± 5.6 vs. 2.21 ± 0.6 μmol/L, respectively). In silico searches identified a CpG-rich region in the 5′ portion of the Soat2 gene, which was differentially methylated (P < 0.05) in Cbs +/- mice fed the HH diet than in Cbs +/+ mice fed the control diet and was accompanied by higher (P < 0.05) B1 repeat element methylation, an indicator of global de novo methylation. These findings show altered methylation and expression of Soat2/ACAT2 in liver from mice with HHcy and suggest a role for changes in liver CE in the pathology of HHcy.

AB - Alterations in lipid metabolism may contribute to the pathology of hyperhomocysteinemia (HHcy). Our objective in this study was to test the hypothesis that HHcy is associated with changes in liver acyl CoA:cholesterol acyl transferase 2 (ACAT2) expression and cholesteryl esters (CE) in mice with HHcy. ACAT2 is encoded by Soat2 and functions to catalyze the esterification of cholesterol with acyl-CoA. Mice heterozygous for disruption of the cystathionine-β-synthase gene (Cbs +/-) and C57BL/6 mice (Cbs +/+) were fed a control diet or a diet high in L-methionine (8.60 g/kg) and low in folic acid (0.20 mg/kg) to induce HHcy (HH diet). Lower Soat2 mRNA (P < 0.05) and ACAT protein (P < 0.001), higher total oleic acid [18:1(n-9)], and lower CE 18:1(n-9) was found in liver from Cbs +/2 mice fed the HH diet, with higher plasma total homocysteine concentrations, than Cbs +/+ mice fed the control diet (35.01 ± 5.6 vs. 2.21 ± 0.6 μmol/L, respectively). In silico searches identified a CpG-rich region in the 5′ portion of the Soat2 gene, which was differentially methylated (P < 0.05) in Cbs +/- mice fed the HH diet than in Cbs +/+ mice fed the control diet and was accompanied by higher (P < 0.05) B1 repeat element methylation, an indicator of global de novo methylation. These findings show altered methylation and expression of Soat2/ACAT2 in liver from mice with HHcy and suggest a role for changes in liver CE in the pathology of HHcy.

UR - http://www.scopus.com/inward/record.url?scp=74949110792&partnerID=8YFLogxK

U2 - 10.3945/jn.109.112920

DO - 10.3945/jn.109.112920

M3 - Article

VL - 140

SP - 231

EP - 237

JO - Journal of Nutrition

JF - Journal of Nutrition

SN - 0022-3166

IS - 2

ER -